AYTU
Aytu BioPharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AYTU fundamentals
Aytu BioPharma (AYTU) released its earnings on Nov 13, 2025: revenue was 13.89M (YoY -16.21%), beat estimates; EPS was -0.08 (YoY +60.00%), beat estimates.
Revenue / YoY
13.89M
-16.21%
EPS / YoY
-0.08
+60.00%
Report date
Nov 13, 2025
AYTU Earnings Call Summary for Q1,2026
- EXXUA Launch Momentum: On track for Q4 2025 launch with 40-person sales force leveraging RxConnect for 85% of ADHD prescriptions. EXXUA's unique benefits (no sexual dysfunction, weight neutral) position it as a MDD disruptor.
- ADHD Resilience: Q1 2026 revenue $13.2M (10% growth vs. prior year, excluding rebate). AG of Adzenys launched in Q3 2025 with strong early adoption, mitigating generic risk.
- Financial Focus: EXXUA launch investment of $10M FY2026, with 28% royalty structure enabling margin expansion at scale. Q1 2026 cash breakeven at $16.6M net revenue.
EPS
Revenue
Revenue & Expenses
AYTU has released its 2026 Q1 earnings report, with revenue of 13.89M, reflecting a YoY change of -16.21%, and net profit of 1.97M, showing a YoY change of 33.31%. The Sankey diagram below clearly presents AYTU's revenue sources and cost distribution.
Key Indicators
Aytu BioPharma (AYTU) key financial stats and ratios, covering profitability, financial health, and leverage.
Aytu BioPharma (AYTU)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Aytu BioPharma (AYTU)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Aytu BioPharma (AYTU)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Aytu BioPharma (AYTU) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Aytu BioPharma (AYTU) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Aytu BioPharma's earnings call?Did Aytu BioPharma beat or miss consensus estimates last quarter?What is Aytu BioPharma's gross profit margin?What is the market's earnings forecast for Aytu BioPharma next quarter?What is Aytu BioPharma's latest dividend and current dividend yield?What does Aytu BioPharma do and what are its main business segments?What is the revenue and EPS growth rate for Aytu BioPharma year over year?What factors drove the changes in Aytu BioPharma's revenue and profit?
